Candel Therapeutics, Inc. · NASDAQ:CADL
BlackRock, Inc.'s stake in Candel Therapeutics, Inc. fell to 4.20% (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 27, 2026
BlackRock, Inc.'s stake in Candel Therapeutics, Inc. fell to 4.20%, 3,079,861 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G/A).
- Stake
- 4.20%
- Shares
- 3,079,861
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.20% | 3,079,861 |
Source
Related
- Candel Therapeutics, Inc.
- BlackRock, Inc.
- Candel Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Form 4 · Tak Paul Peter · Sep 11, 2026
- Form 4 · Tyagarajan Seshu · Aug 19, 2026
- Form 4 · Barone Francesca · Jul 1, 2026
- Form 4 · Tyagarajan Seshu · Jul 1, 2026
- Schedule 13G · Rtw Investments, LP · May 15, 2026